LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status
Authors
Keywords
-
Journal
Frontiers in Molecular Neuroscience
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-06-24
DOI
10.3389/fnmol.2014.00054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
- (2014) Loukia Parisiadou et al. NATURE NEUROSCIENCE
- Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain
- (2014) J. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
- (2013) Evy Lobbestael et al. BIOCHEMICAL JOURNAL
- Differential Effects of Familial Parkinson Mutations in LRRK2 Revealed by a Systematic Analysis of Autophosphorylation
- (2013) Shogo Kamikawaji et al. BIOCHEMISTRY
- Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation
- (2013) Izabella D. Greene et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
- (2013) Michael G. Heckman et al. NEUROBIOLOGY OF AGING
- Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
- (2013) Marco A. S. Baptista et al. PLoS One
- Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
- (2013) K. Muda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
- (2012) Iakov N. Rudenko et al. BIOCHEMICAL JOURNAL
- GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
- (2012) A. Biosa et al. HUMAN MOLECULAR GENETICS
- Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
- (2012) Anthony A. Estrada et al. JOURNAL OF MEDICINAL CHEMISTRY
- Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation
- (2012) Spencer B. Hermanson et al. PLoS One
- Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
- (2012) Z. Sheng et al. Science Translational Medicine
- Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
- (2012) Christina M. Lill et al. PLoS Genetics
- LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
- (2011) Martin C. Herzig et al. HUMAN MOLECULAR GENETICS
- LRRK2 Parkinson disease mutations enhance its microtubule association
- (2011) Lauren R. Kett et al. HUMAN MOLECULAR GENETICS
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
- (2011) Philip J. Webber et al. JOURNAL OF MOLECULAR BIOLOGY
- Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition
- (2011) Elizabeth A. Doggett et al. JOURNAL OF NEUROCHEMISTRY
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
- (2011) Owen A Ross et al. LANCET NEUROLOGY
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
- (2011) Xianting Li et al. PLoS One
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans
- (2010) Suzanne Lesage et al. HUMAN MOLECULAR GENETICS
- Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2
- (2010) Xiaojie Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
- (2010) Veronique Daniëls et al. JOURNAL OF NEUROCHEMISTRY
- Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
- (2010) Christian Johannes Gloeckner et al. JOURNAL OF PROTEOME RESEARCH
- Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
- (2010) Vesna Sossi et al. MOVEMENT DISORDERS
- Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
- (2010) Pooja P. Pungaliya et al. PLoS One
- Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
- (2009) Elisa Greggio et al. ASN Neuro
- Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
- (2009) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Identification of the Autophosphorylation Sites of LRRK2
- (2009) Shogo Kamikawaji et al. BIOCHEMISTRY
- LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
- (2009) Javier Alegre-Abarrategui et al. HUMAN MOLECULAR GENETICS
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Clinical features of LRRK2 parkinsonism
- (2009) Kristoffer Haugarvoll et al. PARKINSONISM & RELATED DISORDERS
- The WD40 Domain Is Required for LRRK2 Neurotoxicity
- (2009) Nathan D. Jorgensen et al. PLoS One
- Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
- (2008) Owen A. Ross et al. ANNALS OF NEUROLOGY
- Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
- (2008) Saskia Biskup et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- LRRK2 R1628P increases risk of Parkinson’s disease: replication evidence
- (2008) E. K. Tan et al. HUMAN GENETICS
- Comprehensive analysis ofLRRK2in publicly available Parkinson's disease cases and neurologically normal controls
- (2008) Coro Paisán-Ruíz et al. HUMAN MUTATION
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
- (2008) Elisa Greggio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
- (2008) K. Haugarvoll et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search